Skip to main content
. 2022 Jan 7;17(8):1809–1813. doi: 10.4103/1673-5374.332155

Table 1.

Baseline demographics for participants in ta-VNS and control groups

Characteristics ta-VNS (n = 30) Control (n = 30) P-value
Male 15(50) 14(47) 0.79
Age (yr) 69.2±12.3 68.3±12.1 0.48
Type of stroke (ischemic/hemorrhagic) 27/3 28/2 0.64
Days post-stroke 10.8±7.7 10.4±6.9 0.90
Handedness (right/left/ambidextrous) 27/2/1 29/0/1 0.35
Stroke hemisphere (right/left) 12/18 10/20 0.59
FMA-U 31.4±5.7 30.8±5.3 0.74
FMA-L 17.6±3.0 17.2±2.9 0.62
FMA-S 13.2±4.0 12.9±3.8 0.92
Stroke impact scale 143.1±57.2 129.7±53.2 0.06
HADS-A 10.9±1.9 11.3±2.0 0.05
HADS-D 8.3±1.4 8.5±1.5 0.43

Data are expressed as number (percentage) (male), number (type of stroke, handedness, stroke hemisphere) or mean ± SD (other data). Student’s t-test was used for continuous variables, and the Chi-square test was used for categorical variables. FMA-L: Fugl-Meyer assessment–lower extremity; FMA-S: Fugl-Meyer assessment–sensory; FMA-U: Fugl-Meyer assessment–upper extremity; HADS-A: Hospital Anxiety and Depression Scale–Anxiety scale; HADS-D: Hospital Anxiety and Depression Scale–Depression scale.